It’s the latest in a string of deals for Lilly, which has sunk more than $18 billion into acquisitions over the past few years.
An article from
Pain drugs
It’s the latest in a string of deals for Lilly, which has sunk more than $18 billion into acquisitions over the past few years.
Published June 16, 2026
A flag flies above the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana.
The deals are part of Eli Lilly’s effort to expand into infectious disease research and development.
Worth close to $4 billion combined, the acquisitions of Curevo, LimmaTech and Vaccine Co. signal plans by Lilly to build an…
Eli Lilly announced Tuesday that it is acquiring Curevo Inc., LimmaTech Biologics AG and Vaccine Company, Inc., in deals totaling…
The drugmaker announced it will buy three privately held vaccine makers in deals worth almost $4 billion combined.
The Indianapolis-based company expanded its spend to ensure it can meet growing demand for its weight-loss drugs.
Eli Lilly’s takeover of Engage Bio marks the seventh acquisition for the big pharma since the start of 2026.
